V
Vijay Kumar
Researcher at All India Institute of Medical Sciences
Publications - 419
Citations - 9160
Vijay Kumar is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Innate immune system. The author has an hindex of 39, co-authored 375 publications receiving 6841 citations. Previous affiliations of Vijay Kumar include University of Toronto & University of Queensland.
Papers
More filters
Journal ArticleDOI
Direct determination of diploid genome sequences
TL;DR: This work demonstrates a straightforward and low-cost method for creating true diploid de novo assemblies, and provides a scalable capability for determining the actual diploids genome sequence in a sample, opening the door to new approaches in genomic biology and medicine.
Journal ArticleDOI
Neutrophils: Cinderella of innate immune system.
Vijay Kumar,Amit Sharma +1 more
TL;DR: The present review is intended to highlight the emerging role of neutrophils in the regulation of both innate and adaptive immunity during acute infectious or inflammatory conditions.
Journal ArticleDOI
Obesity and osteoarthritis
TL;DR: It is found that despite slower initial recovery and possibly lower functional scores and implant survival in the longer term, obese patients can still benefit from TKA in terms of improved function, quality of life and satisfaction.
Book ChapterDOI
Distributed Search and Rescue with Robot and Sensor Teams
George Kantor,Sanjiv Singh,Ronald Peterson,Daniela Rus,Aveek Das,Vijay Kumar,Guilherme A. S. Pereira,John R. Spletzer +7 more
TL;DR: A network of distributed mobile sensor systems as a solution to the emergency response problem and how such networks can assist human users to find an exit is developed.
Journal ArticleDOI
Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury
TL;DR: The differences in immune response depending on the causal pathogen (Gram-positive or Gram-negative bacteria) associated pneumonia or sepsis-induced ALI should be taken in mind specific immune-based therapeutics.